Surgical resection of medulla oblongata hemangioblastomas: outcome and complications

Lorenzo Giammattei1,2, Mahmoud Messerer3,4, Nozar Aghakhani3

  • 1Department of Neurosurgery, Bicêtre University Hospital, Le Kremlin-Bicêtre, France. lore1985nch@gmail.com.

Abstract

Insights

Surgery for medulla oblongata hemangioblastomas is complex but offers favorable long-term outcomes. While transient complications occur, patient outcomes improve over time, especially for those not severely neurologically impaired pre-surgery.

Area of Science:

  • Neurosurgery
  • Oncology
  • Neurology

Background:

  • Medulla oblongata (MO) hemangioblastomas are rare tumors.
  • Surgical intervention is the primary treatment modality.
  • Understanding surgical outcomes and complications is crucial for patient management.

Purpose of the Study:

  • To analyze the surgical outcomes and complications associated with medulla oblongata hemangioblastomas.
  • To evaluate the long-term functional status of patients following surgery.
  • To identify predictors of surgical outcomes.

Main Methods:

  • Retrospective review of 27 patients (31 procedures) operated on between 1996 and 2015.
  • Pre- and postoperative MRI scans were obtained for all patients.
  • Karnofsky Performance Scale (KPS) and McCormick Scale were used for functional assessment.

Main Results:

  • 93% of patients had von Hippel Lindau (VHL) disease.
  • 23% of operations resulted in neurological aggravation at discharge.
  • Long-term follow-up showed KPS improvement in 53% of patients and stability in 40%.

Conclusions:

  • Surgery for MO hemangioblastomas is challenging with acceptable morbidity.
  • Transient morbidity is common, but long-term outcomes are generally favorable.
  • Preoperative neurological status is a key predictor of surgical success.

Related Concept Videos